linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Ajanta Pharma Ltd.
 
Source DateBoard Meeting DateDetails
21 Apr 202605 May 2026 Audited Results & Quarterly Results
12 Jan 202630 Jan 2026 Quarterly Results
08 Oct 202503 Nov 2025 Quarterly Results & Interim Dividend
16 Jul 202528 Jul 2025 Quarterly Results
22 Apr 202530 Apr 2025 A.G.M. & Audited Results
17 Jan 202530 Jan 2025 Quarterly Results
17 Oct 202428 Oct 2024 Quarterly Results
18 Jul 202430 Jul 2024 Quarterly Results
22 Apr 202402 May 2024 Buy Back of Shares & Quarterly Results & Audited Results
19 Jan 202431 Jan 2024 Second Interim Dividend & Quarterly Results
19 Oct 202331 Oct 2023 Quarterly Results
24 Jul 202327 Jul 2023 Interim Dividend & Quarterly Results
14 Jul 202327 Jul 2023 Quarterly Results
27 Apr 202305 May 2023 Audited Results
06 Mar 202310 Mar 2023 Buy Back of Shares
23 Jan 202301 Feb 2023 Quarterly Results
21 Oct 202203 Nov 2022 Quarterly Results & Interim Dividend
20 Jul 202228 Jul 2022 Quarterly Results
02 May 202210 May 2022 Bonus issue & Audited Results
21 Jan 202231 Jan 2022 Quarterly Results
Page 1 of 5
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.